Nadezda Lukacova Selected Research

tezampanel

1/2015	Thoracic 9 Spinal Transection-Induced Model of Muscle Spasticity in the Rat: A Systematic Electrophysiological and Histopathological Characterization.
9/2012	Development of AMPA receptor and GABA B receptor-sensitive spinal hyper-reflexia after spinal air embolism in rat: a systematic neurological, electrophysiological and qualitative histopathological study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadezda Lukacova Research Topics

Disease

5	Spinal Cord Injuries (Spinal Cord Injury) 02/2022 - 10/2006
3	Muscle Spasticity (Spastic) 01/2018 - 09/2012
2	Inflammation (Inflammations) 01/2020 - 04/2018
2	Wounds and Injuries (Trauma) 01/2019 - 01/2015
2	Hyperalgesia 07/2013 - 12/2002
1	Hypothermia 01/2018
1	Spinal Injuries (Spinal Injury) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2017
1	Neuralgia (Stump Neuralgia) 04/2017
1	Pain (Aches) 07/2013
1	Paraplegia (Spastic Paraplegia) 09/2012
1	Air Embolism (Gas Embolism) 09/2012
1	Ischemia 10/2006
1	Reperfusion Injury 10/2006
1	Spinal Cord Ischemia 10/2006
1	MPTP Poisoning 11/2004

Drug/Important Bio-Agent (IBA)

2	Neuroprotective AgentsIBA 01/2020 - 01/2018
2	Angiotensin IIIBA 04/2017 - 07/2013
2	tezampanelIBA 01/2015 - 09/2012
2	Baclofen FDA LinkGeneric 01/2015 - 09/2012
2	AMPA Receptors (AMPA Receptor)IBA 01/2015 - 09/2012
1	Nerve Growth Factors (Neurotrophins)IBA 02/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2022
1	CholesterolIBA 04/2018
1	Atorvastatin (Lipitor)FDA Link 04/2018
1	Glycine Plasma Membrane Transport ProteinsIBA 01/2018
1	OligonucleotidesIBA 01/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018
1	NeuropeptidesIBA 04/2017
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2015
1	tizanidine (Zanaflex)FDA LinkGeneric 01/2015
1	Losartan (Cozaar)FDA LinkGeneric 07/2013
1	GABA-B Receptor AgonistsIBA 09/2012
1	GABA-B ReceptorsIBA 09/2012
1	NADP (NADPH)IBA 10/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2006
1	NADPH Dehydrogenase (Dehydrogenase, NADP)IBA 10/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2006
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 11/2004

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2018 - 01/2015
2	Ligation 04/2017 - 12/2002
1	Endurance Training 02/2022
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Therapeutics 01/2019
1	Injections 09/2012